Our ROC curve analysis revealed that the IgA and IgG antibody levels of specific antibodies against RBD of SARS-CoV-2 may be useful for serological diagnosis of COVID-19 patients in the convalescent period when the molecular methods have a limited diagnostic role in all infectious diseases including SARS-CoV-2. This evidence concerns the gene CD79A and COVID-19.